Yuichi Sakamori
Wakayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Correction: Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells.
Journal: Cancer research
Published: June 26, 2026
Successful Plasma Exchange and Steroid Maintenance Therapy for Severe Pembrolizumab-Induced Polyradiculoneuritis in Lung Cancer: A Case Report.
Journal: Case reports in oncology
Published: September 19, 2025
Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells.
Journal: Cancer research
Published: August 04, 2025
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for EGFR L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED Analysis.
Journal: JTO clinical and research reports
Published: June 16, 2025
Successful treatment with pembrolizumab for microsatellite instability-high thymic carcinoma: A case report.
Journal: Respiratory medicine case reports
Published: February 10, 2025
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).
Journal: Therapeutic advances in medical oncology
Published: February 07, 2025
Improvement of survival outcomes in patients with advanced-stage non-small-cell lung cancer treated with chemotherapy: a retrospective cohort study evaluating the role of immune checkpoint inhibitors.
Journal: Journal of thoracic disease
Published: December 18, 2024
Characteristics and outcomes of salvage surgery after immune checkpoint inhibitor therapy for initially unresectable non-small cell lung cancer.
Journal: Journal of thoracic disease
Published: May 30, 2024
Re-evaluation and operative indications after induction therapy for thymic epithelial tumors.
Journal: Mediastinum (Hong Kong, China)
Published: December 18, 2023
Narrative review of indication and management of induction therapy for thymic epithelial tumors.
Journal: Mediastinum (Hong Kong, China)
Published: December 08, 2023
Author Correction: Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
Journal: Scientific reports
Published: February 07, 2023
Last Updated: 09/26/2026